7-Phenylheptanoic acid, 97.0%, 250mg

2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 10g

N-(tert-Butoxycarbonyl)-D-leucine Monohydrate>98.0%(T)25g

5-methyl-2,4-hexanedione, 95.0%, 100mg

4-Bromosalicylaldehyde>98.0%(GC)(T)1g

(2R,3R,4R,5R)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)-3-methyltetrahydrofuran-3,4-diol, 98%, 10mg

(S)-TERT-BUTYL BUT-3-YN-2-YLCARBAMATE, 95.0%, 10g

4-(Phenylethynyl)aniline, 95%, 1g

Methyl 3-bromo-4-chloro-5-methylbenzoate, 95%, 500mg

Recipiente di reazione a flangia piatta, cilindrico, graduato, con camicia di rinvenimento e sottovuoto e valvola di scarico, DN 60, 250 ml, 160 mm, 1 Pezzo

[1-(2,4-Dichloro-benzenesulfonyl)-piperidin-2-yl]-methanol, 95.0%, 100mg

3-(azepan-1-ylsulfonyl)benzoic acid, 1g

3-(3-(4-Fluorophenyl)-1,2,4-oxadiazol-5-yl)propanoic acid, 95.0%, 10g